Patent Assignment
Reel/Frame 051475/0639
Assignment of Assignor's Interest
Recorded: 2020-01-10
Pages: 5
Assignor
MASON, RICHARD PRESTON
Executed: 2019-08-05
Assignee
AMARIN PHARMACEUTICALS IRELAND LIMITED
2 PEMBROKE HOUSE, UPPER PEMBROKE STREET 28-32, DUBLIN, 2, IRELAND
Covered Properties
(3)
Methods reducing or preventing oxidation of high density lipoprotein (HDL)
Application:
15/998,570 →
Publication:
US 2019/0054054
Methods of Reducing or Preventing Oxidation of High Density Lipoprotein (HDL)
Application:
62/545,809 →
Methods of Reducing or Preventing Oxidation of High Density Lipoprotein (HDL)
Application:
62/586,268 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Assignment and Assumption Agreement
Dec 20, 2017
From: BIOPHARMA SECURED DEBT FUND II HOLDINGS CAYMAN LP
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044956/0395 →
Security Interest
Dec 21, 2017
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044938/0257 →
Release of Security Interest
Nov 19, 2020
From: CPPIB CREDIT EUROPE S.À R.L.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 054484/0552 →